You have 9 free searches left this month | for more free features.

decitabine,

Showing 426 - 450 of 493

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome Trial in Ulsan (Lenalidomide)

Unknown status
  • Myelodysplastic Syndrome
  • Ulsan, Korea, Republic of
    Ulsan University Hospital
May 10, 2016

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • Columbus, Ohio
    Ohio State University Medical Center
Nov 6, 2014

Colorectal Cancer Trial in Salt Lake City (Dacogen™ (decitabine), Vectibix® (panitumumab))

Completed
  • Colorectal Cancer
  • Dacogen™ (decitabine)
  • Vectibix® (panitumumab)
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Oct 29, 2014

Ovarian Cancer Trial in Indianapolis (decitabine)

Completed
  • Ovarian Cancer
  • Indianapolis, Indiana
    Indiana University Cancer Center
Sep 19, 2014

MDS Trial in United States (decitabine, azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • Birmingham, Alabama
  • +18 more
Oct 21, 2014

Acute Lymphocytic Leukemia Trial in Houston (Decitabine)

Completed
  • Acute Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 13, 2014

Leukemia, Myeloid, Acute Trial in St. Louis (Decitabine, Bexarotene)

Completed
  • Leukemia, Myeloid, Acute
  • St. Louis, Missouri
    Washington University School of Medicine
Jul 28, 2014

Metastatic Melanoma Trial in Siena (SGI-110, Ipilimumab)

Unknown status
  • Metastatic Melanoma
  • Siena, Italy
    Medical Oncology and Immunotherapy Unit, University Hospital of
Nov 16, 2015

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Untreated Adult Acute Myeloid Leukemia Trial in Seoul, Ulsan (Nilotinib+AD

Unknown status
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • Untreated Adult Acute Myeloid Leukemia
  • Nilotinib+AD induction
  • Seoul, Korea, Republic of
  • +1 more
May 10, 2016

Myelodysplastic Syndrome Trial in Singapore (Decitabine)

Terminated
  • Myelodysplastic Syndrome
  • Singapore, Singapore
    Singapore General Hospital
Jun 16, 2014

Primary Malignant Tumor of Ovary, FIGO Stages II to IV Trial in Beijing (Decitabine (DTC Arm), Paclitaxel and Carboplatin (TC

Recruiting
  • Primary Malignant Neoplasm of Ovary
  • FIGO Stages II to IV
  • Decitabine (DTC Arm)
  • Paclitaxel and Carboplatin (TC Arm)
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jun 9, 2014

Thalassemia Trial in Oakland, Philadelphia, Toronto (Decitabine (USAN, INN))

Completed
  • Thalassemia
  • Decitabine (USAN, INN)
  • Oakland, California
  • +2 more
Apr 9, 2014

Solid Tumor Trial in Las Vegas (biological, drug, other)

Terminated
  • Unspecified Adult Solid Tumor, Protocol Specific
  • peginterferon alfa-2b
  • +2 more
  • Las Vegas, Nevada
    Nevada Cancer Institute-Summerlin Campus
Feb 21, 2014

During Second Cycle of Decitabine Can Predict Response and

Unknown status
  • Myelodysplastic Syndrome
    • Seoul, Korea, Republic of
      Division of Hematology Oncology, Samsung Medical Center
    Jan 23, 2014

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Hackensack (Decitabine plus Fludarabine and Busulfan)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Decitabine plus Fludarabine and Busulfan
    • Hackensack, New Jersey
      Hackensack University Medical Center - John Theurer Cancer Cente
    Feb 1, 2014

    Chronic Myelomonocytic Leukemia Trial in France (Decitabine)

    Completed
    • Chronic Myelomonocytic Leukemia
    • Le Kremlin-Bicêtre, Ile de France, France
    • +30 more
    Mar 19, 2014

    Myelodysplastic Syndrome Trial in Tianjin (Decitabine Injection)

    Unknown status
    • Myelodysplastic Syndrome
    • Decitabine Injection
    • Tianjin, Tianjin, China
      Tianjin Medical University General Hospital
    Dec 11, 2013

    Myelodysplastic Syndrome Trial in Japan (JNJ-30979754 15 mg/m2, JNJ-30979754 20 mg/m2)

    Completed
    • Myelodysplastic Syndrome
    • JNJ-30979754 15 mg/m2
    • JNJ-30979754 20 mg/m2
    • Fukuoka, Japan
    • +6 more
    Oct 10, 2013

    Myelodysplastic Syndrome Trial in United States (decitabine)

    Completed
    • Myelodysplastic Syndrome
    • Canton, Ohio
    • +3 more
    Sep 18, 2013

    Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

    Completed
    • Anemia, Cooley's
    • +6 more
    • Oakland, California
    • +4 more
    Mar 3, 2014

    Myelodysplastic Syndrome (MDS) Trial in Worldwide (Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG))

    Terminated
    • Myelodysplastic Syndrome (MDS)
    • Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG)
    • Paris, France
    • +6 more
    Mar 17, 2015

    Recurrent NSCLC, Stage IV NSCLC Trial in Columbus (decitabine, valproic acid, pharmacological study)

    Completed
    • Recurrent Non-small Cell Lung Cancer
    • Stage IV Non-small Cell Lung Cancer
    • Columbus, Ohio
      Ohio State University Medical Center
    Sep 27, 2013

    MDS Trial in Durham (Lenalidomide, Decitabine)

    Completed
    • Myelodysplastic Syndromes
    • Lenalidomide, Decitabine
    • Durham, North Carolina
      Duke University Medical Center
    Sep 6, 2013

    Recurrent Neuroblastoma, Child Solid Tumor Trial in Arcadia (drug, biological, other)

    Completed
    • Recurrent Neuroblastoma
    • Unspecified Childhood Solid Tumor, Protocol Specific
    • Arcadia, California
      Children's Oncology Group
    Sep 27, 2013

    Myelodysplastic Syndrome Trial in Taiwan (Decitabine)

    Completed
    • Myelodysplastic Syndrome
    • Changhua, Taiwan
    • +5 more
    Aug 26, 2013